Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$4.44

0.295 (7.13%)

16:04
12/12/17
12/12
16:04
12/12/17
16:04

Fate Therapeutics announces common stock offering

Fate Therapeutics announced that it has commenced an underwritten public offering of its common stock. Fate Therapeutics intends to use the net proceeds from the offering for clinical development and research activities, working capital and other general corporate purposes. Leerink Partners and Piper Jaffray are acting as joint book-running managers for the offering.

  • 14

    Dec

FATE Fate Therapeutics
$4.44

0.295 (7.13%)

10/12/17
HCWC
10/12/17
INITIATION
Target $7
HCWC
Buy
Fate Therapeutics assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Edward White assumed coverage of Fate Therapeutics with a Buy rating and $7 price target. The analyst projects revenues of $329M and $68M for ProTmune and NK-100, respectively, in 2026.
09/08/17
09/08/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with a Top Pick at RBC Capital. 2. Electronic Arts (EA) was initiated with a Conviction Buy while Activision Blizzard (ATVI) was initiated with a Neutral at Goldman Sachs. 3. AB InBev (BUD) initiated with a Buy at Argus. 4. LivaNova (LIVN) initiated with a Buy at Jefferies. 5. Fate Therapeutics (FATE) resumed with an Outperform at Leerink. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/17
LEER
09/08/17
INITIATION
Target $7
LEER
Outperform
Fate Therapeutics resumed with an Outperform at Leerink
Leerink analyst Michael Schmidt resumed coverage of Fate Therapeutics with an Outperform rating and $7 price target. The analyst believes Fate has generated a "compelling" platform and pipeline with "significant potential" to disrupt the cellular immunotherapy space.

TODAY'S FREE FLY STORIES

TBPH

Theravance Biopharma

$28.10

-0.32 (-1.13%)

, JNJ

Johnson & Johnson

$139.12

0.44 (0.32%)

15:06
10/23/18
10/23
15:06
10/23/18
15:06
Recommendations
Theravance Biopharma, Johnson & Johnson analyst commentary  »

Piper says Theravance…

TBPH

Theravance Biopharma

$28.10

-0.32 (-1.13%)

JNJ

Johnson & Johnson

$139.12

0.44 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 13

    Nov

  • 27

    Nov

  • 18

    Dec

15:05
10/23/18
10/23
15:05
10/23/18
15:05
General news
More from Bostic and Kaplan: Bostic favors raising rates four times this year »

More from Bostic and…

RRC

Range Resources

$16.52

-0.18 (-1.08%)

15:04
10/23/18
10/23
15:04
10/23/18
15:04
Options
Range Resources options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

15:01
10/23/18
10/23
15:01
10/23/18
15:01
Hot Stocks
NY DFS authorizes Coinbase Global to form Coinbase Custody Trust Company »

New York Financial…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$51.59

-0.05 (-0.10%)

15:01
10/23/18
10/23
15:01
10/23/18
15:01
Hot Stocks
Wells Fargo raises share repurchase authority by 350M shares »

The Wells Fargo board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

HLT

Hilton

$69.20

-0.97 (-1.38%)

15:00
10/23/18
10/23
15:00
10/23/18
15:00
Options
Hilton options see continued interest ahead of earnings »

Hilton options see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

15:00
10/23/18
10/23
15:00
10/23/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TSLA

Tesla

$292.51

31.48 (12.06%)

14:55
10/23/18
10/23
14:55
10/23/18
14:55
Hot Stocks
Citron's Left says would be 'wrong' to be short Tesla ahead of Q3 report »

Citron Research's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IBTX

Independent Bank

$57.55

1.08 (1.91%)

14:54
10/23/18
10/23
14:54
10/23/18
14:54
Recommendations
Independent Bank analyst commentary  »

Independent Bank price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Nov

HXL

Hexcel

14:52
10/23/18
10/23
14:52
10/23/18
14:52
Upgrade
Hexcel rating change  »

Hexcel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CVE

Cenovus Energy

$8.53

-0.085 (-0.99%)

14:50
10/23/18
10/23
14:50
10/23/18
14:50
Options
Afternoon call buyer in Cenovus Energy »

Afternoon call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:50
10/23/18
10/23
14:50
10/23/18
14:50
General news
Fed's Kaplan reiterated the FOMC should gradual reduce accommodation »

Fed's Kaplan…

TXN

Texas Instruments

$99.84

0.1 (0.10%)

14:49
10/23/18
10/23
14:49
10/23/18
14:49
Options
Texas Instruments options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BIIB

Biogen

$319.27

3.6 (1.14%)

14:47
10/23/18
10/23
14:47
10/23/18
14:47
Recommendations
Biogen analyst commentary  »

Piper a buyer of Biogen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

TSLA

Tesla

$292.44

31.41 (12.03%)

14:44
10/23/18
10/23
14:44
10/23/18
14:44
Hot Stocks
Musk says Tesla will cut some interior configuration options for Model S, X »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

VNQ

Vanguard REIT Index Fund

$77.68

0.64 (0.83%)

14:40
10/23/18
10/23
14:40
10/23/18
14:40
Options
66K Vanguard Real Estate Fund Dec 76 - Jan 72 put spreads trade 71c »

66K Vanguard Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEEV

Veeva

$88.99

-2.77 (-3.02%)

14:35
10/23/18
10/23
14:35
10/23/18
14:35
Options
Veeva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
10/23/18
10/23
14:35
10/23/18
14:35
General news
Fed Board minutes showed showed most Banks supported the September 26 rate hike »

Fed Board minutes showed…

TSLA

Tesla

$292.00

30.97 (11.86%)

14:32
10/23/18
10/23
14:32
10/23/18
14:32
Recommendations
Tesla analyst commentary  »

Tesla's moved up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

TTWO

Take-Two

$118.82

-1.69 (-1.40%)

14:30
10/23/18
10/23
14:30
10/23/18
14:30
Periodicals
'Red Dead Redemption 2' development a difficult experience, Kotaku says »

Take-Two's Rockstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

, HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

14:29
10/23/18
10/23
14:29
10/23/18
14:29
Recommendations
Selecta Biosciences, Horizon Pharma analyst commentary  »

Selecta SEL-212 data…

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/23/18
10/23
14:17
10/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.